Literature DB >> 12050852

[Amyloid cascade hypothesis of Alzheimer's disease and alpha 7 nicotinic receptor].

Kenji Hashimoto1, Masaomi Iyo.   

Abstract

It is known that beta amyloid protein (A beta) plays an important role in the pathology of Alzheimer's disease (AD). In this review, the role of cellular signaling in the protective action of nicotine for A beta-induced neurotoxicity is described. Recent biochemical and functional studies have demonstrated that A beta interacts directly with the alpha 7 nicotinic receptor, suggesting that A beta might have a function as an endogenous ligand for this receptor. Thus the role of alpha 7 nicotinic receptor in the A beta cascade hypothesis of AD and the possibility of alpha 7 nicotine receptor agonists as the therapeutic drugs for AD are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050852

Source DB:  PubMed          Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi        ISSN: 1340-2544


  4 in total

1.  Novel therapeutic drugs for neuropsychiatric disorders.

Authors:  Kenji Hashimoto
Journal:  Open Med Chem J       Date:  2010-05-27

2.  Brain imaging of nicotinic receptors in Alzheimer's disease.

Authors:  Jin Wu; Masatomo Ishikawa; Jichun Zhang; Kenji Hashimoto
Journal:  Int J Alzheimers Dis       Date:  2010-12-28

3.  α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.

Authors:  Jun Toyohara; Kenji Hashimoto
Journal:  Open Med Chem J       Date:  2010-05-27

4.  Focal-type, but not Diffuse-type, Amyloid Beta Plaques are Correlated with Alzheimer's Neuropathology, Cognitive Dysfunction, and Neuroinflammation in the Human Hippocampus.

Authors:  Fan Liu; Jianru Sun; Xue Wang; Sixuan Jin; Fengrun Sun; Tao Wang; Bo Yuan; Wenying Qiu; Chao Ma
Journal:  Neurosci Bull       Date:  2022-08-26       Impact factor: 5.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.